Abstract: An intelligent energy system includes an energy-consuming appliance, a battery module coupled to the appliance, and a bidirectional converter coupled to the appliance and the battery module by a power bus. The battery module is configured to provide power to the appliance. The bidirectional converter converts between alternating current (AC) and direct current (DC) and interfaces with a power infrastructure external to the appliance. The system further includes a control unit communicatively coupled to the battery module, the bidirectional converter, and the appliance. The control unit is configured to determine a charge and discharge schedule for the battery module. The battery module coupled with the bidirectional converter provides uninterrupted power to the appliance, abstracts the power demands of the appliance from local power infrastructure, and allows for greater appliance peak power draw than would otherwise be practical or possible.

Abstract: Biocompatible microparticles include an ophthalmically active cyclic lipid component and a biodegradable polymer that is effective, when placed into the subconjunctival space, in facilitating release of the cyclic lipid component into the anterior and posterior segments of an eye for an extended period of time. The cyclic lipid component can be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. Or, the cyclic lipid component can be encapsulated by the polymeric component. The present microparticles include oil-in-water emulsified microparticles. The subconjunctivally administered microparticles can be used to treat or to reduce at least one symptom of an ocular condition, such as glaucoma or age related macular degeneration.

Abstract: The invention provides an injectable composition and method for the minimally invasive, in-situ repair and regeneration of an injured ligament or tendon in a mammalian subject. The composition is also useful for the delivery of growth factors, therapeutic agents and cells into the area of tendon or ligament injury.

Abstract: Biocompatible microparticles include an ophthalmically active cyclic lipid component and a biodegradable polymer that is effective, when placed into the subconjunctival space, in facilitating release of the cyclic lipid component into the anterior and posterior segments of an eye for an extended period of time. The cyclic lipid component can be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. Or, the cyclic lipid component can be encapsulated by the polymeric component. The present microparticles include oil-in-water emulsified microparticles. The subconjunctivally administered microparticles can be used to treat or to reduce at least one symptom of an ocular condition, such as glaucoma or age related macular degeneration.

Abstract: Provided are methods for treating a musculoskeletal tissue interface injury using decellularized, allogeneic or xenogeneic composite tissue bioscaffolds.

Abstract: A fuel cell assembly includes a fuel cell stack including a plurality of fuel cells, an incoming oxidizing gas flow path configured to deliver an oxidizing gas to the plurality of fuel cells, and a chromium-getter material located in the incoming oxidizing flow path. A fuel cell includes an electrolyte, a cathode electrode on a first side of the electrolyte, an anode electrode on a second side of the electrolyte, and a chromium-getter material on the cathode electrode.

Abstract: A distributed computer system and method for synchronizing content libraries in replication groups uses a synchronization control signal that is transmitted to a subscribed content library management module of each subscribed content library in a replication group from a content library management module of the master content library in the replication group to initiate a synchronization procedure. Using metadata of at least one consumable software item from the master content library, contents of a subscribed content library in the replication group are modified to synchronize its contents to the contents of the master content library.

Abstract: A fuel cell assembly includes a fuel cell stack including a plurality of fuel cells, an incoming oxidizing gas flow path configured to deliver an oxidizing gas to the plurality of fuel cells, and a chromium-getter material located in the incoming oxidizing flow path. A fuel cell includes an electrolyte, a cathode electrode on a first side of the electrolyte, an anode electrode on a second side of the electrolyte, and a chromium-getter material on the cathode electrode.

Abstract: Biocompatible microparticles include an ophthalmically active cyclic lipid component and a biodegradable polymer that is effective, when placed into the subconjunctival space, in facilitating release of the cyclic lipid component into the anterior and posterior segments of an eye for an extended period of time. The cyclic lipid component can be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. Or, the cyclic lipid component can be encapsulated by the polymeric component. The present microparticles include oil-in-water emulsified microparticles. The subconjunctivally administered microparticles can be used to treat or to reduce at least one symptom of an ocular condition, such as glaucoma or age related macular degeneration.

Abstract: Biocompatible microparticles include an ophthalmically active cyclic lipid component and a biodegradable polymer that is effective, when placed into the subconjunctival space, in facilitating release of the cyclic lipid component into the anterior and posterior segments of an eye for an extended period of time. The cyclic lipid component can be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. Or, the cyclic lipid component can be encapsulated by the polymeric component. The present microparticles include oil-in-water emulsified microparticles. The subconjunctivally administered microparticles can be used to treat or to reduce at least one symptom of an ocular condition, such as glaucoma or age related macular degeneration.

Abstract: Biocompatible microparticles include an ophthalmically active cyclic lipid component and a biodegradable polymer that is effective, when placed into the subconjunctival space, in facilitating release of the cyclic lipid component into the anterior and posterior segments of an eye for an extended period of time. The cyclic lipid component can be associated with a biodegradable polymer matrix, such as a matrix of a two biodegradable polymers. Or, the cyclic lipid component can be encapsulated by the polymeric component. The present microparticles include oil-in-water emulsified microparticles. The subconjunctivally administered microparticles can be used to treat or to reduce at least one symptom of an ocular condition, such as glaucoma or age related macular degeneration.

Abstract: The invention provides an injectable composition and method for the minimally invasive, in-situ repair and regeneration of an injured ligament or tendon in a mammalian subject. The composition is also useful for the delivery of growth factors, therapeutic agents and cells into the area of tendon or ligament injury.

Abstract: The invention provides an injectable composition and method for the minimally invasive, in-situ repair and regeneration of an injured ligament or tendon in a mammalian subject. The composition is also useful for the delivery of growth factors, therapeutic agents and cells into the area of tendon or ligament injury.

Abstract: A fuel cell assembly includes a fuel cell stack including a plurality of fuel cells, an incoming oxidizing gas flow path configured to deliver an oxidizing gas to the plurality of fuel cells, and a chromium-getter material located in the incoming oxidizing flow path. A fuel cell includes an electrolyte, a cathode electrode on a first side of the electrolyte, an anode electrode on a second side of the electrolyte, and a chromium-getter material on the cathode electrode.

Abstract: Provided are methods for treating a musculoskeletal tissue interface injury using decellularized, allogeneic or xenogeneic composite tissue bioscaffolds.

Abstract: A coated substrate may provide soft touch and superhydrophobicity. In example implementations herein, a substrate may be provided with a microstructure on at least a portion of at least one surface of the substrate. A first, water-based soft touch coating may be on at least a portion of the microstructure. A second, solvent-based superhydrophobic coating may be on at least a portion of the first coating.

Abstract: A distributed computer system and method for synchronizing content libraries in replication groups uses a synchronization control signal that is transmitted to a subscribed content library management module of each subscribed content library in a replication group from a content library management module of the master content library in the replication group to initiate a synchronization procedure. Using metadata of at least one consumable software item from the master content library, contents of a subscribed content library in the replication group are modified to synchronize its contents to the contents of the master content library.

Abstract: A coated substrate may provide soft touch and superhydrophobicity. In example implementations herein, a substrate may be provided with a microstructure on at least a portion of at least one surface of the substrate. A first, water-based soft touch coating may be on at least a portion of the microstructure. A second, solvent-based superhydrophobic coating may be on at least a portion of the first coating.